Trial Profile
Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Aug 2011
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- 24 Jan 2008 Status changed from in progress to completed from ClinicalTrials.gov update.
- 26 Jun 2007 New trial record.